TrialInternational journal of hematology2018

Efficacy and safety of obinutuzumab in patients with previously untreated follicular lymphoma: a subgroup analysis of patients enrolled in Japan in the randomized phase III GALLIUM trial.

Ken Ohmachi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.